- Home
- TKNO vs SOPH Comparison
TKNO vs SOPH Comparison
Compare TKNO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- SOPH
- Stock Information
- Founded
- TKNO 1996
- SOPH 2011
- Country
- TKNO United States
- SOPH Switzerland
- Employees
- TKNO N/A
- SOPH N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TKNO Health Care
- SOPH Health Care
- Exchange
- TKNO Nasdaq
- SOPH Nasdaq
- Market Cap
- TKNO 390.7M
- SOPH 226.6M
- IPO Year
- TKNO 2021
- SOPH 2021
- Fundamental
- Price
- TKNO $7.73
- SOPH $3.26
- Analyst Decision
- TKNO Buy
- SOPH Strong Buy
- Analyst Count
- TKNO 2
- SOPH 3
- Target Price
- TKNO $5.00
- SOPH $7.00
- AVG Volume (30 Days)
- TKNO 195.0K
- SOPH 21.3K
- Earning Date
- TKNO 11-07-2024
- SOPH 11-05-2024
- Dividend Yield
- TKNO N/A
- SOPH N/A
- EPS Growth
- TKNO N/A
- SOPH N/A
- EPS
- TKNO N/A
- SOPH N/A
- Revenue
- TKNO $36,347,000.00
- SOPH $64,488,000.00
- Revenue This Year
- TKNO $3.47
- SOPH $7.20
- Revenue Next Year
- TKNO $12.07
- SOPH $15.71
- P/E Ratio
- TKNO N/A
- SOPH N/A
- Revenue Growth
- TKNO N/A
- SOPH 9.85
- 52 Week Low
- TKNO $1.16
- SOPH $2.70
- 52 Week High
- TKNO $8.91
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- TKNO 51.60
- SOPH 46.64
- Support Level
- TKNO $7.00
- SOPH $3.06
- Resistance Level
- TKNO $8.89
- SOPH $3.47
- Average True Range (ATR)
- TKNO 0.74
- SOPH 0.18
- MACD
- TKNO -0.09
- SOPH -0.00
- Stochastic Oscillator
- TKNO 38.24
- SOPH 45.45
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.